![An infographic that explains the benefits of full therapeutic value for patients like Patrick. It has a blue background with white text and an illustration of Patrick in the center. The illustration is of a man with his arms crossed and a serious expression on his face. <br /><br />On the left side of the image there is a line graph that shows hours on the x-axis and the pain plasma hydromorphone level on the y-axis demonstrating that "Exalgo remained above 50% of C[?] for more than 90% of dosing interval" as compared to hydromorphone. <br /><br />The right side of the graphic has recommended instructions on how best to treat a patient like Patrick with Exalgo and also has important risk information for Exalgo.](https://oida-resources-images.azureedge.net/public/full/3d05d7df-6b4f-46b4-a36b-ee5f924ecb77.png)
Title
Description 
An infographic that explains the benefits of full therapeutic value for patients like Patrick. It has a blue background with white text and an illustration of Patrick in the center. The illustration is of a man with his arms crossed and a serious expression on his face.
On the left side of the image there is a line graph that shows hours on the x-axis and the pain plasma hydromorphone level on the y-axis demonstrating that "Exalgo remained above 50% of C[?] for more than 90% of dosing interval" as compared to hydromorphone.
The right side of the graphic has recommended instructions on how best to treat a patient like Patrick with Exalgo and also has important risk information for Exalgo.
Type
Category
Drug
Exalgo
Source 1 of 9
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2011
Collection
-
Date
2012
Collection
-
Date
2011
Collection
-
Date
2011
Collection
-
Date
2012
Collection
-
Date
2012
Collection
-
Date
2011
Collection
We encourage you to view the image in the context of its source document(s) and cite the source(s) when using these images. However, to cite just this image alone, click the “Cite This Image” button and then paste the copied text.
